Home

The AAD.org reports:

Dr. Baldwin also added that a new oral medication on the horizon could be another viable alternative for acne patients in the next few years. Incyclinide, a chemically modified tetracycline that is not an antibiotic, is now in phase two of clinical trials and shows promise in treating both acne and rosacea. "We´re hopeful that the new systemic acne medications will lead to improved treatment outcomes for acne patients," said Dr. Baldwin. "However, with so many treatment options available, it´s important that acne patients involve a dermatologist to oversee their treatment regimen - as only a dermatologist can determine which acne medications are best for each patient."